| Year |
Title |
Altmetric |
| 2021
|
Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma
2021
|
|
| 2021
|
Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.
Cancer Medicine.
10:5712-5720.
2021
|
|
| 2020
|
HPV-EM: an accurate HPV detection and genotyping EM algorithm.
Scientific Reports.
10.
2020
|
|
| 2020
|
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.
Nature Communications.
11.
2020
|
|
| 2020
|
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Nature Communications.
11.
2020
|
|
| 2020
|
Sex differences in oncogenic mutational processes.
Nature Communications.
11.
2020
|
|
| 2020
|
Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade–specific epigenome and transcriptome landscapes.
Nature Genetics.
52:800-810.
2020
|
|
| 2020
|
The landscape of viral associations in human cancers.
Nature Genetics.
52:320-330.
2020
|
|
| 2020
|
Genomic basis for RNA alterations in cancer.
Nature.
578:129-136.
2020
|
|
| 2020
|
Pan-cancer analysis of whole genomes.
Nature.
578:82-93.
2020
|
|
| 2019
|
Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.
Molecular Genetics and Genomic Medicine.
7.
2019
|
|
| 2019
|
Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023)).
Immunity.
51:411-412.
2019
|
|
| 2018
|
GATK PathSeq: A customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts.
Bioinformatics.
34:4287-4289.
2018
|
|
| 2018
|
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.
Nature Communications.
9.
2018
|
|
| 2018
|
Erratum: Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (Cell (2017) 171(3) (540–556.e25) (S0092867417310565) (10.1016/j.cell.2017.09.007)).
Cell.
174:1033.
2018
|
|
| 2018
|
The Immune Landscape of Cancer.
Immunity.
48:812-830.e14.
2018
|
|
| 2018
|
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
Cancer Cell.
33:690-705.e9.
2018
|
|
| 2018
|
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Cancer Cell.
33:721-735.e8.
2018
|
|
| 2018
|
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Cell Reports.
23:194-212.e6.
2018
|
|
| 2017
|
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
Cell.
171:540-556.e25.
2017
|
|
| 2017
|
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.
American Journal of Obstetrics and Gynecology.
217:432.e1-432.e17.
2017
|
|
| 2017
|
Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033)).
Cell Reports.
19:2878-2880.
2017
|
|
| 2017
|
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
Cell.
169:1327-1341.e23.
2017
|
|
| 2017
|
Integrated genomic and molecular characterization of cervical cancer.
Nature.
543:378-384.
2017
|
|
| 2017
|
Integrated genomic characterization of oesophageal carcinoma.
Nature.
541:169-174.
2017
|
|
| 2017
|
Pathway-structured predictive model for cancer survival prediction: A two-stage approach
2017
|
|
| 2016
|
Notch signaling activation is associated with patient mortality and increased FGF1-mediated invasion in squamous cell carcinoma of the oral cavity
2016
|
|
| 2016
|
Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Breast Cancer Research and Treatment.
157:575-586.
2016
|
|
| 2016
|
Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach
2016
|
|
| 2016
|
Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's Disease.
Cellular and Molecular Gastroenterology and Hepatology.
2:563-566.e5.
2016
|
|
| 2015
|
Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.
International Journal of Cancer.
137:776-783.
2015
|
|
| 2015
|
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Nature.
517:576-582.
2015
|
|
| 2015
|
The tumor virus landscape of AIDS-related lymphomas.
Blood.
125:e14-e22.
2015
|
|
| 2014
|
Characterization of HPV and host genome interactions in primary head and neck cancers
2014
|
|
| 2014
|
Integrated Genomic Characterization of Papillary Thyroid Carcinoma.
Cell.
159:676-690.
2014
|
|
| 2014
|
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature.
513:202-209.
2014
|
|
| 2014
|
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell.
158:929-944.
2014
|
|
| 2014
|
Landscape of genomic alterations in cervical carcinomas.
Nature.
506:371-375.
2014
|
|
| 2013
|
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Nature Genetics.
45:1483-1486.
2013
|
|
| 2013
|
The cancer genome atlas pan-cancer analysis project.
Nature Genetics.
45:1113-1120.
2013
|
|
| 2013
|
Abstract 4604: Landscape of human and viral genomic alterations in cervical carcinomas..
Molecular and Cellular Biology.
2013
|
|
| 2013
|
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.
New England Journal of Medicine.
369:517-528.
2013
|
|
| 2012
|
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
2012
|
|
| 2012
|
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
2012
|
|
| 2012
|
Pathogen discovery in AIDS-related lymphoma by high-throughput sequencing..
Infectious Agents and Cancer.
7:P45-P45.
2012
|
|
| 2011
|
PathSeq: Software to identify or discover microbes by deep sequencing of human tissue.
Nature Biotechnology.
29:393-396.
2011
|
|
| 2011
|
Abstract 949: PathSeq: A comprehensive computational tool for pathogen discovery by deep sequencing of human cancer tissues.
Epidemiology.
2011
|
|
| 2008
|
Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG.
AIDS Research and Human Retroviruses.
24:1167-1174.
2008
|
|
| 2007
|
Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.
AIDS Research and Human Retroviruses.
23:1587-1591.
2007
|
|
| 2007
|
The complexity of circulating HIV type 1 strains in Oyo State, Nigeria.
AIDS Research and Human Retroviruses.
23:1020-1025.
2007
|
|
| 2006
|
HIV-1 subtype and reverse transcriptase genotype: Role for geographical location and founder effects [7].
PLoS Medicine.
3:2462-2463.
2006
|
|
| 2006
|
Subtype-specific patterns in HIV type 1 reverse transcriptase and protease in Oyo State, Nigeria: Implications for drug resistance and host response.
AIDS Research and Human Retroviruses.
22:770-779.
2006
|
|
| 2005
|
Launching into the deep: the musings of a budding physician-scientist.
Archives of Ibadan Medicine.
6.
2005
|
|
| 2004
|
Correspondence [2] (multiple letters).
Journal of Pediatric Surgery.
39:1446-1447.
2004
|
|
| 2002
|
Decline in the frequency of Burkitt's lymphoma relative to other childhood malignancies in Ibadan, Nigeria.
Annals of Tropical Paediatrics.
22:159-163.
2002
|
|
| 2000
|
Improving the Medical Curriculum.
DOKITA.
27:23-28.
2000
|
|
| 1999
|
Congenital Heart Disease.
DOKITA.
26:49-54.
1999
|
|
| 1998
|
Paediatric Oncology I: Basic Concepts.
DOKITA.
25:47-50.
1998
|
|
| 1997
|
Spero Meliora.
DOKITA.
24:viii-viii.
1997
|
|
| 1997
|
The Red Eye.
DOKITA.
24:1-8.
1997
|
|
| 1996
|
Serological Diagnosis of Viral Hepatitis A, B, C, D, E..
DOKITA.
23:22-26.
1996
|
|
| |
Paediatric Oncology II: Childhood Neoplasia in Ibadan.
DOKITA.
25:50-55.
|
|
